Most just lately, it's been recognized that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in identical locations as classical opioid receptors, it binds to the wide array of endogenous opioids. Compared with most opioid receptors, t